Prognostic significance of Bcl-2 in clinically localized prostate cancer.

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Prognostic significance of Bcl-2 in clinically localized prostate cancer.

The American journal of pathology - 1 May 1996

Bubendorf L, Sauter G, Moch H, Jordan P, Blöchlinger A, Gasser T C, Mihatsch M J

Abstract excerpt

The clinical course of prostate cancer is highly variable and cannot satisfactorily be predicted by histological criteria alone. To study the prognostic significance of Bcl-2 and p53 overexpression in prostate cancer, 137 consecutive radical prostatectomy specimens were examined by immunohistoche...

Topics

Aged
Aged, 80 and over
Apoptosis
Cell Division
Disease Progression
Humans
Immunohistochemistry
Ki-67 Antigen
Linear Models
Male
Middle Aged
Neoplasm Proteins
Nuclear Proteins
Phenotype
Prognosis
Prostatic Neoplasms
Proto-Oncogene Proteins
Proto-Oncogene Proteins c-bcl-2

Source

Open in PubMed Open full text

Identifiers

PMID: 8623924
PMCID: PMC1861580

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-8623924-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics